Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults
Nicole Bézay, Romana Hochreiter, Vera Kadlecek, Nina Wressnigg, Julian Larcher‐Senn, Anton Klingler, Katrin Dubischar, Susanne Eder-Lingelbach, Isabel Leroux‐Roels, Geert Leroux‐Roels, Wolfgang Bender
Topics & Concepts
Borrelia burgdorferiAdverse effectMedicineImmunogenicityInternal medicineVaccinationLyme borreliosisRandomized controlled trialImmunologyAntibodyVector-borne infectious diseasesBacterial Infections and Vaccinesvaccines and immunoinformatics approaches